About Centro de Estudos em Diabetes e Hipertensão
Clinical Trials at Centro de Estudos em Diabetes e Hipertensão
During the past decade, Centro de Estudos em Diabetes e Hipertensão conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Estudos em Diabetes e Hipertensão"
#1 collaborator was "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 3 trials as a collaborator, "ANS Pharma" with 1 trials as a collaborator, "Centro de Estudos em Diabetes e Hipertensão" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Federal University of Pelotas" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Centro de Estudos em Diabetes e Hipertensão
According to Clinical.Site data, the most researched conditions in "Centro de Estudos em Diabetes e Hipertensão" are
"Diabetes Mellitus, Type 2" (3 trials), "Diabetes Mellitus" (2 trials), "Complications of Diabetes Mellitus" (1 trials), "Diabetes, Gestational" (1 trials) and "Diabetes-Related Complications" (1 trials). Many other conditions were trialed in "Centro de Estudos em Diabetes e Hipertensão" in a lesser frequency.
Clinical Trials Intervention Types at Centro de Estudos em Diabetes e Hipertensão
Most popular intervention types in "Centro de Estudos em Diabetes e Hipertensão" are "Drug" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Diacerein" (2 trials), "Placebo" (2 trials), "Evogliptin" (1 trials), "Placebo Evogliptin" (1 trials) and "Placebo Sitagliptin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro de Estudos em Diabetes e Hipertensão
The vast majority of trials in "Centro de Estudos em Diabetes e Hipertensão" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Centro de Estudos em Diabetes e Hipertensão
Currently, there are NaN active trials in "Centro de Estudos em Diabetes e Hipertensão".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Centro de Estudos em Diabetes e Hipertensão,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Estudos em Diabetes e Hipertensão, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".